Business
MedMira to Collaborate with the National Research Council of Canada on Advanced Sensitivity and Automated Detection in Future Rapid Diagnostics
HALIFAX , Nov. 12, 2013 /CNW/ - MedMira Inc., (MedMira) (TSXV: MIR), a developer of rapi...
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\nHALIFAX, Nov. 12, 2013 /CNW/ - MedMira Inc., (MedMira) (TSXV: MIR), a\n developer of rapid diagnostic technology and solutions, today announced\n a collaborative research agreement with the National Research Council\n of Canada (NRC). MedMira is aiming to advance its rapid diagnostic\n technology through the creation of a next generation rapid diagnostics\n platform, specifically for diseases and conditions which today can only\n be diagnosed using traditional laboratory based tests, processes, and\n equipment.\n\n\nMedMira will receive funding support towards this research from the\n National Research Council of Canada Industrial Research Assistance\n Program (NRC IRAP).  MedMira and NRC will work together over a 10 month\n period on two key areas that will expand the capabilities of MedMira's\n rapid diagnostic technology platform. The first will develop new\n nanoparticles that are more visible than traditional particles,\n allowing earlier diagnosis of diseases. In addition to making the\n detection more sensitive it also broadens the scope of applications\n that can be built on the rapid flow-through technology platform. With\n these advancements, certain diseases and medical conditions, which\n today may be below the detection limits for all rapid assays, could\n soon be detected in minutes, at the point-of-care, using a MedMira\n rapid test.\n\n\n\"This is a valuable opportunity to bring together research and\n development efforts from both MedMira and the National Research Council\n to deliver superior healthcare tools more rapidly than we could alone,\"\n said Dr. Neeraj Vats, Director of Technology and Business Affairs,\n MedMira Inc.\n\n\nThe second advancement will involve NRC and MedMira conducting research\n and development activities leading to the addition of non-visual\n detection in the rapid diagnostic platform. Automating the reading and\n recording of test results brings significant operational efficiencies\n to healthcare providers, faster treatment for patients, and better\n surveillance data in large scale screening programs run by health\n departments and aid organizations.\n\n\nDr. Vats added \"In addition to broadening the scope of applications that\n can be created on rapid tests, we are also working to enhance the user\n experience. The development of simple instrumentation that can\n inte...